AVX-420

N/A

Report date: 2024/12/20 10:59:13
NMEFirst In Class

Base Information

Drug NameAVX-420
Drug Alias NameAVX420AVX-420FOL-026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhospholipases A2 inhibitors
TargetsPhospholipases A2
Therapy Area/IndicationsRenal fibrosisLiver CirrhosisLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoegin Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesCoegin Pharma AB
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsRenal fibrosisLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A